Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia
By:
References
- 1. REEFMAN E, KUİPER H, JONKMAN MF, et al. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. Rheumatology. 2006; 45:538-44.
- 2. SARZİ-PUTTİNİ P, ATZENİ F, CAPSONİ F, et al. Drug induced lupus erythematosus. Autoimmunity. 2005; 38:507-18.
- 3. MARZANO AV, VEZZOLİ P, CROSTİ C. Drug-induced lupus: an update on its dermatologic aspects. Lupus. 2009; 18:935-40.
- 4. KATZ U, ZANDMAN-GODDARD G. Drug-induced lupus: an update. Autoimmun Rev. 2010; 10:46-50.
- 5. KİNDEM S, LLOMBART B, REQUENA C, et al. Subacute cutaneous lupus erythematosus after treatment with capecitabine. J Dermatol. 2013; 40:75-6.
- 6. FERNANDES NF, ROSENBACH M, ELENİTSAS R, KİST JM. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. Arch Dermatol. 2009; 145:340-1.
- 7. KO JH, HSİEH CI, CHOU CY, WANG KH. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test. J Dermatol. 2013; 40:939-40.
- 8. WEGER W, KRÄNKE B, GERGER A, et al. Occurrence of subacute cutaneous lupus erythematosusafter treatment with fluorouracil and capecitabine. J Am Acad Dermatol. 2008; 59:4-6.
- 9. FLORİSTAN U, FELTES RA, SENDAGORTA E, et al. Subacute cutaneous lupus erythematosus induced by capecitabine. Clin Exp Dermatol. 2009; 34:328-9.
- 10. WİESENTHAL A, MATHERNE R, GİBSON B. Capecitabine-induced systemic lupuserythematosus and palmoplantar erythrodysesthesia. J Drugs Dermatol. 2012; 11:769-71.
- 11. MERLİN F, PROCHİLO T, KİLDANİ B, et al. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine. Int J Colorectal Dis. 2008; 23:715-6.
- 12. VİHİNEN P, PAİJA O, KİVİSAARİ A, et al. Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. J Med Case Rep. 2011; 5:243.
- 13. DUDLEY K, MİCETİCH K, MASSA MC. Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil. Cutis. 1987; 39:64-6.
- 14. KLUGER N, BESSİS D, GUİLLOT B. Chronic cutaneous lupus flare induced by systemic 5-fluorouracil. J Dermatolog Treat. 2006; 17:51-3.
- 15. MOAZZAM N, MALİK AA, MEHDİ SA, POTTİ A. Treatment side effects. Case 3. Fluorouracil-induced exacerbation of systemic lupus erythematosus. J Clin Oncol. 2002; 20:3032-4.
- 16. YOSHİMASU T, HİROİ A, UEDE K, FURUKAWA F. Discoid lupus erythematosus (DLE)-like lesion induced by uraciltegafur (UFT). Eur J Dermatol. 2001; 11:54-7.
- 17. ALMAGRO BM, STEYLS MC, NAVARRO NL, et al. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil. J Clin Oncol. 2011; 29:613-5.
Language: English
Page range: 282 - 285
Submitted on: May 1, 2015
Published on: Oct 14, 2015
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2015 Ersin Ozaslan, Eray Eroglu, Kevser Gok, Soner Senel, Suleyman Baldane, Lutfi Akyol, Metin Ozkan, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution 4.0 License.